Jonas Kloepper
Molecular Biology · 2018
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 38 citations into it
- Cancer Research — 14 citations into it
Whom Jonas Kloepper trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Jonas Kloepper's perspective
Ordered by how strongly the researchers Jonas Kloepper trusts endorse each paper. Same corpus, a different order for every researcher.
- Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy (Science)
- The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
- Angiopoietin-1 protects the adult vasculature against plasma leakage (Nature Medicine)
- Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. (Cancer Research)
- Pathology: Cancer cells compress intratumour vessels (Nature)
- Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. (Cancer Cell)
- Deciphering and reversing tumor immune suppression. (Immunity)
- Modes of resistance to anti-angiogenic therapy (Nature Reviews. Cancer)
- Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)
Their papers
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) — 1,744 citations